Follow-The-Filings

Security · featured owners

PCVX Vaxcyte Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.8%
  • $94M
  • 1 add 2 exits

PCVX (Vaxcyte Inc.) is held in 1 featured 13F book as of 2026 Q2. Lee Ainslie - Maverick Capital is the largest tracked holder by portfolio weight (0.83%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.8% (Lee Ainslie - Maverick Capital) · not free-float ownership

  1. Lee Ainslie Add 0.83%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Lee Ainslie - Maverick Capital 2026 Q2 0.83% Add +17.1% 1,613,242 $94M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 0.42% Exit −0.42% 1,261,000 $73M History
Seth Klarman - Baupost Group exited 2026 Q2 Last 2026 Q1 0.91% Exit −0.91% 800,000 $46M History

1 current · 2 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Sep 4, 2026 · 2 forms Filing Doc
4 Period Sep 8, 2026 · 4 forms Filing Doc
4 Period Aug 31, 2026 · 5 forms Filing Doc
4 Period Aug 3, 2026 · 2 forms Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Jul 27, 2026 Filing Doc
4 Period Jul 16, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jul 6, 2026 Filing Doc
4 Period Jun 26, 2026 Filing Doc
4 Period Jun 22, 2026 Filing Doc
4 Period Jun 18, 2026 · 2 forms Filing Doc
4 Period Jun 15, 2026 · 3 forms Filing Doc

Updated 19 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$402.27M -$463.93M -$766.63M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.1B $1.79B $1.63B
Total non-current assets $0.312B $1.72B $1.38B
Total assets $1.41B $3.51B $3B
Total current liabilities $145.34M $140.18M $205.75M
Total non-current liabilities * $22.11M $65.32M $111.46M
Total equity $1.24B $3.31B $2.69B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$296.79M -$452.63M -$655.58M
Cash from investing -$0.773B -$2.01B $0.437B
Cash from financing $0.64B $2.45B $0.002B
Net change in cash -$436.97M -$9.36M -$213.77M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders